Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

PMID: 35822847
Journal: Future cardiology
Year: 2022
Reference: Future Cardiol. 2022 Jul 13. doi: 10.2217/fca-2022-0044.
Impact factor: 0
Publication type: Review in international publication
Authors: Barrios, Vivencio, Cinza-Sanjurjo, Sergio, Garcia-Alegria, Javier, Freixa-Pamias, Roman, Llordachs-Marques, Frederic, Molina, Carlos A, Santamaria, Amparo, Suarez Fernandez, Carmen, Vivas, David et al.
DOI: 10.2217/fca-2022-0044

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

PMID: 35822847
Journal: Future cardiology
Year: 2022
Reference: Future Cardiol. 2022 Sep;18(9):743-754. doi: 10.2217/fca-2022-0044. Epub 2022 Jul 13.
Impact factor:
Publication type: Review in international publication
Authors: Barrios, Vivencio; Cinza-Sanjurjo, Sergio; Freixa-Pamias, Roman; Garcia-Alegria, Javier; Llordachs-Marques, Frederic; Molina, Carlos A; Santamaria, Amparo; Suarez Fernandez, Carmen; Vivas, David et al.
DOI: 10.2217/fca-2022-0044

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

PMID: 34786958
Journal: AMERICAN JOURNAL OF ROENTGENOLOGY
Year: 2022
Reference: AJR Am J Roentgenol. 2022 Jul;219(1):26-27. doi: 10.2214/AJR.21.27069. Epub 2021 Nov 17.
Impact factor: 3.959
Publication type: Letter whit IF
Authors: Rovira, Alex, Auger, Cristina et al.
DOI: 10.2214/AJR.21.27069

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

PMID: 34786958
Journal: AMERICAN JOURNAL OF ROENTGENOLOGY
Year: 2022
Reference: AJR Am J Roentgenol. 2022 Jul;219(1):26-27. doi: 10.2214/AJR.21.27069. Epub 2021 Nov 17.
Impact factor:
Publication type: Letter whit IF
Authors: Auger, Cristina; Rovira, Alex et al.
DOI: 10.2214/AJR.21.27069

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

PMID: 35617047
Journal: JOURNAL OF CLINICAL INVESTIGATION
Year: 2022
Reference: J Clin Invest. 2022 Jul 1;132(13). pii: 145660. doi: 10.1172/JCI145660.
Impact factor: 14.808
Publication type: Paper in international publication
Authors: Smeets, H J M, Gorman, Grainne S, Bonnen, Penelope E, Taylor, Robert W, Hirano, Michio, Chinnery, Patrick F, Rodenburg, Richard J, Tanji, Kurenai, Shintaku, Jonathan, Pernice, Wolfgang M et al.
DOI: 10.1172/JCI145660

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

PMID: 35617047
Journal: JOURNAL OF CLINICAL INVESTIGATION
Year: 2022
Reference: J Clin Invest. 2022 Jul 1;132(13). pii: 145660. doi: 10.1172/JCI145660.
Impact factor:
Publication type: Paper in international publication
Authors: Blakely, Emma L; Bonnen, Penelope E; Brown, Zuben P; Chinnery, Patrick F; Donaldson, Alan; Eyaid, Wafaa; Frank, Joachim; Gc, Jeevan B; Gorman, Grainne S; Hellebrekers, Debby Mei et al.
DOI: 10.1172/JCI145660

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

PMID: 35298906
Journal: LANCET ONCOLOGY
Year: 2022
Reference: Lancet Oncol. 2022 Apr;23(4):465-478. doi: 10.1016/S1470-2045(22)00122-X. Epub 2022 Mar 14.
Impact factor: 41.316
Publication type: Paper in international publication
Authors: de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni et al.
DOI: 10.1016/S1470-2045(22)00122-X

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

PMID: 35298906
Journal: LANCET ONCOLOGY
Year: 2022
Reference: Lancet Oncol. 2022 Apr;23(4):465-478. doi: 10.1016/S1470-2045(22)00122-X. Epub 2022 Mar 14.
Impact factor:
Publication type: Paper in international publication
Authors: Biela, Luciano; Bondarenko, Igor; Cibula, David; Colombo, Nicoletta; de Melo, Andreia Cristina; Dvorkin, Mikhail; Fedenko, Alexander; Goble, Sandra; Kristeleit, Rebecca; Lin, Kevin K et al.
DOI: 10.1016/S1470-2045(22)00122-X

Rumination syndrome, critical review.

PMID: 34023479
Journal: Gastroenterologia y Hepatologia
Year: 2022
Reference: Gastroenterol Hepatol. 2022 Feb;45(2):155-163. doi: 10.1016/j.gastrohep.2021.03.013. Epub 2021 May 21.
Impact factor: 2.102
Publication type: Review in national publication
Authors: Alcala-Gonzalez, L G; Serra, X; Barba, E et al.
DOI: 10.1016/j.gastrohep.2021.03.013

Rumination syndrome, critical review.

PMID: 34023479
Journal: Gastroenterologia y Hepatologia
Year: 2022
Reference: Gastroenterol Hepatol. 2022 Feb;45(2):155-163. doi: 10.1016/j.gastrohep.2021.03.013. Epub 2021 May 21.
Impact factor:
Publication type: Review in national publication
Authors: Alcala-Gonzalez, L G; Barba, E; Serra, X et al.
DOI: 10.1016/j.gastrohep.2021.03.013

Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis.

PMID: 35680967
Journal: npj Breast Cancer
Year: 2022
Reference: NPJ Breast Cancer. 2022 Jun 9;8(1):72. doi: 10.1038/s41523-022-00439-5.
Impact factor: 6.923
Publication type: Paper in international publication
Authors: Cortes, Javier, Carey, Lisa A, Loirat, Delphine, Punie, Kevin, Bardia, Aditya, Dieras, Veronique, Dalenc, Florence, Diamond, Jennifer R, Fontaine, Christel, Rugo, Hope S et al.
DOI: 10.1038/s41523-022-00439-5

Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

PMID: 36027558
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2022
Reference: J Clin Oncol. 2022 Oct 10;40(29):3365-3376. doi: 10.1200/JCO.22.01002. Epub 2022 Aug 26.
Impact factor:
Publication type: Paper in international publication
Authors: Bardia, Aditya; Ciruelos, Eva; Cortes, Javier; Dalenc, Florence; Delaney, Rosemary; Fu, Olivia; Jhaveri, Komal L; Lin, Lanjia; Loirat, Delphine; Marme, Frederik et al.
DOI: 10.1200/JCO.22.01002

Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain.

PMID: 35904132
Journal: Journal of the Pediatric Infectious Diseases Society
Year: 2022
Reference: J Pediatric Infect Dis Soc. 2022 Oct 25;11(10):471-473. doi: 10.1093/jpids/piac076.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilera-Alonso, David; Carrasco-Colom, Jaume; Epalza, Cristina; Escartin-Paredes, Paula; Fumado, Victoria; Grasa, Carlos; Hermoso-Ibanez, Concepcion; Herrero, Blanca; Leoz, Ines; Moraleda, Cinta et al.
DOI: 10.1093/jpids/piac076

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

PMID: 35064011
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Jan;10(1). pii: jitc-2021-003777. doi: 10.1136/jitc-2021-003777.
Impact factor: 13.751
Publication type: Paper in international publication
Authors: Gilbert, Lucy, Tinker, Anna V, Brown, Jubilee, Mathews, Cara, Press, Joshua, Sabatier, Renaud, O'Malley, David M, Samouelian, Vanessa, Boni, Valentina, Duska, Linda et al.
DOI: 10.1136/jitc-2021-003777

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

PMID: 35064011
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Jan;10(1). pii: jitc-2021-003777. doi: 10.1136/jitc-2021-003777.
Impact factor:
Publication type: Paper in international publication
Authors: Boni, Valentina; Brown, Jubilee; Duan, Tao; Duska, Linda; Ghamande, Sharad; Ghatage, Prafull; Gilbert, Lucy; Guo, Wei; Han, Xinwei; Im, Ellie et al.
DOI: 10.1136/jitc-2021-003777

Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease.

PMID: 36275063
Journal: Frontiers in Pediatrics
Year: 2022
Reference: Front Pediatr. 2022 Oct 6;10:967233. doi: 10.3389/fped.2022.967233. eCollection 2022.
Impact factor:
Publication type: Paper in international publication
Authors: Ariceta, Gema; Cruz, Alejandro; Garcia-Ortega, Patricia; Jimenez-Lozano, Ines; Lopez, Mercedes; Lopez, Mercedes; Polo, Aurora Fernandez et al.
DOI: 10.3389/fped.2022.967233

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

PMID: 35171022
Journal: Microbiology Spectrum
Year: 2022
Reference: Microbiol Spectr. 2022 Feb 23;10(1):e0178421. doi: 10.1128/spectrum.01784-21. Epub 2022 Feb 16.
Impact factor: 7.171
Publication type: Paper in international publication
Authors: Monforte, Arnau, Los-Arcos, Ibai, Martin-Gomez, Maria Teresa, Campany-Herrero, David, Sacanell, Judith, Berastegui, Cristina, Marquez-Algaba, Ester, Sempere, Abiu, Nuvials, Xavier, Castells, Lluis et al.
DOI: 10.1128/spectrum.01784-21

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

PMID: 35171022
Journal: Microbiology Spectrum
Year: 2022
Reference: Microbiol Spectr. 2022 Feb 23;10(1):e0178421. doi: 10.1128/spectrum.01784-21. Epub 2022 Feb 16.
Impact factor:
Publication type: Paper in international publication
Authors: Berastegui, Cristina; Bravo, Carles; Campany-Herrero, David; Castells, Lluis; Deu, Maria; Gavalda, Joan; Len, Oscar; Los-Arcos, Ibai; Marquez-Algaba, Ester; Martin-Gomez, Maria Teresa et al.
DOI: 10.1128/spectrum.01784-21

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

PMID: 35203878
Journal: Antibiotics-Basel
Year: 2022
Reference: Antibiotics (Basel). 2022 Feb 19;11(2). pii: antibiotics11020275. doi: 10.3390/antibiotics11020275.
Impact factor: 4.639
Publication type: Review in international publication
Authors: Tejada, Sofia, Forero, Carlos G, Gallego, Miguel, Soriano, Joan B, Cardinal-Fernandez, Pablo A, Ehrmann, Stephan, Rello, Jordi, Ramirez-Estrada, Sergio et al.
DOI: 10.3390/antibiotics11020275

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

PMID: 35203878
Journal: Antibiotics-Basel
Year: 2022
Reference: Antibiotics (Basel). 2022 Feb 19;11(2). pii: antibiotics11020275. doi: 10.3390/antibiotics11020275.
Impact factor:
Publication type: Review in international publication
Authors: Cardinal-Fernandez, Pablo A; Ehrmann, Stephan; Forero, Carlos G; Gallego, Miguel; Ramirez-Estrada, Sergio; Rello, Jordi; Soriano, Joan B; Tejada, Sofia et al.
DOI: 10.3390/antibiotics11020275

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

PMID: 35716692
Journal: LANCET NEUROLOGY
Year: 2022
Reference: Lancet Neurol. 2022 Jul;21(7):597-607. doi: 10.1016/S1474-4422(22)00185-5.
Impact factor: 44.182
Publication type: Paper in international publication
Authors: Lanteri-Minet, Michel; Pozo-Rosich, Patricia; Ettrup, Anders; Christoffersen, Cecilie Laurberg; Josiassen, Mette Krog; Phul, Ravinder; Sperling, Bjorn; Ashina, Messoud et al.
DOI: 10.1016/S1474-4422(22)00185-5

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

PMID: 35716692
Journal: LANCET NEUROLOGY
Year: 2022
Reference: Lancet Neurol. 2022 Jul;21(7):597-607. doi: 10.1016/S1474-4422(22)00185-5.
Impact factor:
Publication type: Paper in international publication
Authors: Ashina, Messoud; Christoffersen, Cecilie Laurberg; Ettrup, Anders; Josiassen, Mette Krog; Lanteri-Minet, Michel; Phul, Ravinder; Pozo-Rosich, Patricia; Sperling, Bjorn et al.
DOI: 10.1016/S1474-4422(22)00185-5

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

PMID: 34942136
Journal: LANCET NEUROLOGY
Year: 2022
Reference: Lancet Neurol. 2022 Jan;21(1):42-52. doi: 10.1016/S1474-4422(21)00367-7.
Impact factor: 44.182
Publication type: Paper in international publication
Authors: Goemans, Nathalie; Mercuri, Eugenio; Deconinck, Nicolas; Mazzone, Elena S; Nascimento, Andres; Oskoui, Maryam; Saito, Kayoko; Vuillerot, Carole; Baranello, Giovanni; Boespflug-Tanguy, Odile et al.
DOI: 10.1016/S1474-4422(21)00367-7

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

PMID: 34942136
Journal: LANCET NEUROLOGY
Year: 2022
Reference: Lancet Neurol. 2022 Jan;21(1):42-52. doi: 10.1016/S1474-4422(21)00367-7.
Impact factor:
Publication type: Paper in international publication
Authors: Abbati, Francesca; Akiyama, Kiyomu; Alemdaroglu, Ipek; Almeida Pereira, Jaqueline; Amorelli, Giulia Maria; Arnoldi, Maria Teresa; Arpin, Stephanie; Ayse Karaduman, Aynur; Balikova, Irina; Balikova, Irina et al.
DOI: 10.1016/S1474-4422(21)00367-7

Publications

Publications searcher

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

Rumination syndrome, critical review.

Rumination syndrome, critical review.

Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis.

Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain.

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease.

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

Patronage:

Collaborating:

Accreditations: